1. Home
  2. FTAIN vs MDWD Comparison

FTAIN vs MDWD Comparison

Compare FTAIN & MDWD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FTAIN
  • MDWD
  • Stock Information
  • Founded
  • FTAIN N/A
  • MDWD 2000
  • Country
  • FTAIN United States
  • MDWD Israel
  • Employees
  • FTAIN 580
  • MDWD N/A
  • Industry
  • FTAIN Misc Corporate Leasing Services
  • MDWD Medicinal Chemicals and Botanical Products
  • Sector
  • FTAIN Industrials
  • MDWD Health Care
  • Exchange
  • FTAIN Nasdaq
  • MDWD Nasdaq
  • Market Cap
  • FTAIN N/A
  • MDWD 208.2M
  • IPO Year
  • FTAIN N/A
  • MDWD 2014
  • Fundamental
  • Price
  • FTAIN $25.49
  • MDWD $20.72
  • Analyst Decision
  • FTAIN
  • MDWD Strong Buy
  • Analyst Count
  • FTAIN 0
  • MDWD 2
  • Target Price
  • FTAIN N/A
  • MDWD $35.00
  • AVG Volume (30 Days)
  • FTAIN N/A
  • MDWD 49.2K
  • Earning Date
  • FTAIN N/A
  • MDWD 08-13-2025
  • Dividend Yield
  • FTAIN N/A
  • MDWD N/A
  • EPS Growth
  • FTAIN N/A
  • MDWD N/A
  • EPS
  • FTAIN N/A
  • MDWD N/A
  • Revenue
  • FTAIN N/A
  • MDWD $19,213,000.00
  • Revenue This Year
  • FTAIN N/A
  • MDWD $20.80
  • Revenue Next Year
  • FTAIN N/A
  • MDWD $26.92
  • P/E Ratio
  • FTAIN N/A
  • MDWD N/A
  • Revenue Growth
  • FTAIN N/A
  • MDWD N/A
  • 52 Week Low
  • FTAIN N/A
  • MDWD $14.14
  • 52 Week High
  • FTAIN N/A
  • MDWD $22.51
  • Technical
  • Relative Strength Index (RSI)
  • FTAIN 63.85
  • MDWD 64.88
  • Support Level
  • FTAIN $25.21
  • MDWD $19.07
  • Resistance Level
  • FTAIN $25.48
  • MDWD $19.55
  • Average True Range (ATR)
  • FTAIN 0.14
  • MDWD 0.65
  • MACD
  • FTAIN 0.04
  • MDWD 0.12
  • Stochastic Oscillator
  • FTAIN 100.00
  • MDWD 94.01

About FTAIN FTAI Aviation Ltd. 8.25% Fixed - Rate Reset Series C Cumulative Perpetual Redeemable Preferred Shares

FTAI Aviation Ltd is a aerospace company .It owns and maintains commercial jet engines with a focus on CFM56 engines. FTAI owns and leases jet aircraft which often facilitates the acquisition of engines at attractive prices. It invests in aviation assets and aerospace products that generate stable cash flows with the potential for earnings growth and asset appreciation.

About MDWD MediWound Ltd.

MediWound Ltd is an integrated biopharmaceutical company focused on developing, manufacturing, and commercializing novel therapeutic products to address unmet medical needs in the fields of severe burns, chronic and other hard-to-heal wounds, connective tissue disorders, and other indications. Its first biopharmaceutical product, NexoBrid is an FDA-approved orphan biologic for eschar removal in severe burns that can replace surgical interventions and minimize associated costs and complications. Its other product candidates in different stages of the pipeline include EscharEx for debridement of chronic wounds, and MW005 for the treatment of non-melanoma skin cancer. The company derives a majority of its revenue from the United States and the rest from the EU and other international markets.

Share on Social Networks: